Top Markets
#1 Seeker Seeker +17.21%
#2 Official Trump Official Trump +12.94%
#3 DeFi Kingdoms DeFi Kingdoms +10.56%
#4 EXOD EXOD +9.04%
#5 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +8.10%
#6 peaq peaq +7.28%
#7 Ethena Staked ENA Ethena Staked ENA +6.55%
#8 TDCCP TDCCP +5.86%
#9 Melania Meme Melania Meme +5.55%
#10 Stacks Stacks +5.26%
Coin of the day
Seeker Seeker
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Onesource Specialty Pharma Ltd. Onesource Specialty Pharma Ltd.

Onesource Specialty Pharma Ltd.

ONESOURCE
Kedudukan dalam Saham #6659
OneSource Specialty Pharma Limited is a biopharmaceutical company focused on... OneSource Specialty Pharma Limited is a biopharmaceutical company focused on the discovery, advancement, production, and market introduction of biological drug products, primarily offered in diverse injectable formulations. The company conducts its operations internationally, with a footprint in India, Ireland, and the United States. It delivers comprehensive contract development and manufacturing (CDMO) services for biologics, encompassing all phases from preclinical and clinical development to commercial-scale supply. Its offerings extend to integrated drug-device systems such as pre-filled syringes, various pen injectors (including dial, push, and pull-push types for both variable and fixed doses), and autoinjectors. Furthermore, OneSource Specialty Pharma manufactures sterile injectable drugs and soft gelatin capsules, and provides specialized biologics solutions tailored for microbial and mammalian cell-line biopharmaceuticals, as well as for cell, gene, and RNA therapies. Established in 2007, the company, headquartered in Bengaluru, India, was formerly known as Stelis Biopharma Limited until its rebranding in February 2024.
Harga Saham
$16.75
Disegerakkan terakhir: 2026-08-27
Modal Pasaran
$1.92B
Perubahan (1 hari)
2.28%
Perubahan (1 tahun)
-20.92%
Negara
IN
Perdagangan Onesource Specialty Pharma Ltd. (ONESOURCE)

Kategori

Healthcare
Nisbah P/E bagi Onesource Specialty Pharma Ltd. (ONESOURCE)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Onesource Specialty Pharma Ltd., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Onesource Specialty Pharma Ltd. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.